Demin Lu1, Jian Chen, Jie Jin. 1. Department of Hematology, First Affiliated Hospital, College of Medicine, Zhejiang University, NO. 79, Qingchun Road, Hangzhou, 310000, People's Republic of China.
Abstract
BACKGROUND: Non-Hodgkin lymphoma (NHL) is among the ten most frequent malignancies in Europe and USA. Results for vitamin D status and risk of NHL have been inconsistent. OBJECTIVE: The objective was to perform a meta-analysis to summarize the available evidence from case-control studies and cohort studies on the association of vitamin D status and the risk of NHL. DESIGN: We searched PubMed, ISI Web of Science, the Cochrane Library, EMBASE, and reference lists for relevant articles. Study-specific odds ratios (ORs) or relative risks and 95 % confidence intervals (CIs) were pooled using fixed-effects, random-effects, or linear regression dose-response models. RESULTS: Nine studies (eight case-control and one cohort studies) were included in the meta-analysis. The estimated summary OR for highest compared with lowest categories of vitamin D status was 1.03 (95 % CI 0.84, 1.26; heterogeneity I (2) = 57.5 %). The subgroup analysis showed the similar results for dietary vitamin D intake group (1.07; 95 % CI 0.82, 1.40) and serum 25-hydroxyvitamin D concentration values group (1.03; 95 % CI 0.84, 1.26). The pooling ORs of NHL most common subtypes were 1.05 (0.73, 1.52), 1.00 (0.63, 1.58), 1.10 (0.56, 2.14), and 1.69 (0.68, 4.20) for diffuse large B cell lymphoma, follicular lymphoma, small lymphocytic lymphomas/chronic lymphocytic leukemia, and T cell lymphoma. The result from the linear regression dose-response model was similar (p = 0.205). CONCLUSIONS: Higher vitamin D status does not play a protective role in risk of NHL or common NHL subtypes.
BACKGROUND:Non-Hodgkin lymphoma (NHL) is among the ten most frequent malignancies in Europe and USA. Results for vitamin D status and risk of NHL have been inconsistent. OBJECTIVE: The objective was to perform a meta-analysis to summarize the available evidence from case-control studies and cohort studies on the association of vitamin D status and the risk of NHL. DESIGN: We searched PubMed, ISI Web of Science, the Cochrane Library, EMBASE, and reference lists for relevant articles. Study-specific odds ratios (ORs) or relative risks and 95 % confidence intervals (CIs) were pooled using fixed-effects, random-effects, or linear regression dose-response models. RESULTS: Nine studies (eight case-control and one cohort studies) were included in the meta-analysis. The estimated summary OR for highest compared with lowest categories of vitamin D status was 1.03 (95 % CI 0.84, 1.26; heterogeneity I (2) = 57.5 %). The subgroup analysis showed the similar results for dietary vitamin D intake group (1.07; 95 % CI 0.82, 1.40) and serum 25-hydroxyvitamin D concentration values group (1.03; 95 % CI 0.84, 1.26). The pooling ORs of NHL most common subtypes were 1.05 (0.73, 1.52), 1.00 (0.63, 1.58), 1.10 (0.56, 2.14), and 1.69 (0.68, 4.20) for diffuse large B cell lymphoma, follicular lymphoma, small lymphocytic lymphomas/chronic lymphocytic leukemia, and T cell lymphoma. The result from the linear regression dose-response model was similar (p = 0.205). CONCLUSIONS: Higher vitamin D status does not play a protective role in risk of NHL or common NHL subtypes.
Authors: Nitin Shivappa; James R Hébert; Martina Taborelli; Maurizio Montella; Massimo Libra; Antonella Zucchetto; Anna Crispo; Maria Grimaldi; Carlo La Vecchia; Diego Serraino; Jerry Polesel Journal: Cancer Causes Control Date: 2017-05-13 Impact factor: 2.506
Authors: Dai Chihara; Loretta J Nastoupil; Jessica N Williams; Paul Lee; Jean L Koff; Christopher R Flowers Journal: Expert Rev Anticancer Ther Date: 2015-04-11 Impact factor: 4.512
Authors: Stefan Hohaus; Maria Chiara Tisi; Silvia Bellesi; Elena Maiolo; Eleonora Alma; Germana Tartaglia; Francesco Corrente; Annarosa Cuccaro; Francesco D'Alo'; Umberto Basile; Luigi Maria Larocca; Valerio De Stefano Journal: Cancer Med Date: 2017-12-22 Impact factor: 4.452